Insider · CIK 0001664251
Barrowcliffe Susan E.
Reports to the SEC for 1 company · BRISBANE, CA
Transactions
45
Companies
1
Filings
5
CIK
0001664251
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2018-11-19 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$121K |
| 2018-11-19 | Aimmune Therapeutics, Inc.S Sale | −$1.2M |
| 2018-11-19 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2018-03-04 | Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2018-03-04 | Aimmune Therapeutics, Inc.A Award | — |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$22.6K |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$917K |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$11.4K |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$906K |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$22.7K |
| 2018-01-02 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2018-01-02 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$227K |
| 2018-01-02 | Aimmune Therapeutics, Inc.S Sale | −$906K |
| 2017-09-25 | Aimmune Therapeutics, Inc.S Sale | −$500K |
| 2017-09-25 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-09-25 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$60.4K |
| 2017-09-06 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$45.8K |
| 2017-09-06 | Aimmune Therapeutics, Inc.S Sale | −$334K |
| 2017-09-06 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-09-05 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-09-05 | Aimmune Therapeutics, Inc.S Sale | −$70.9K |
| 2017-09-05 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$9,739.906 |
| 2017-07-27 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-07-27 | Aimmune Therapeutics, Inc.S Sale | −$11K |
| 2017-07-27 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$1,511 |
| 2017-07-25 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-07-25 | Aimmune Therapeutics, Inc.S Sale | −$102K |
| 2017-07-25 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$14.1K |
| 2017-07-24 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-07-24 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$1,511 |
| 2017-07-24 | Aimmune Therapeutics, Inc.S Sale | −$11K |
| 2017-07-21 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-07-21 | Aimmune Therapeutics, Inc.S Sale | −$21.1K |
| 2017-07-21 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$2,901.12 |
| 2017-07-03 | Aimmune Therapeutics, Inc.S Sale | −$304K |
| 2017-07-03 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2017-07-03 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$45.3K |
| 2017-02-24 | Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2016-11-11 | Aimmune Therapeutics, Inc.S Sale | −$500K |
| 2016-11-11 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$60.4K |
| 2016-11-11 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2016-11-08 | Aimmune Therapeutics, Inc.M Exercise/Conversion | +$45.3K |
| 2016-11-08 | Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2016-11-08 | Aimmune Therapeutics, Inc.S Sale | −$300K |
| 2016-02-26 | Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4Barrowcliffe Susan E.0000899243-18-029542SEC(opens sec.gov)
- 4Barrowcliffe Susan E.0000899243-18-006569SEC(opens sec.gov)
- 4Barrowcliffe Susan E.0000899243-18-000454SEC(opens sec.gov)
- 4Barrowcliffe Susan E.0000899243-17-022643SEC(opens sec.gov)
- 4Barrowcliffe Susan E.0000899243-17-021595SEC(opens sec.gov)
Companies
Address
C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300
BRISBANE, CA, 94005-1884